(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.40%) $78.07
(0.23%) $2.21
(-0.37%) $2 315.70
(-0.63%) $27.37
(-0.23%) $986.10
(0.16%) $0.931
(0.39%) $10.94
(0.17%) $0.801
(-0.01%) $91.43
0.00% $ 119.99
Live Chart Being Loaded With Signals
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland...
Stats | |
---|---|
Dzisiejszy wolumen | 330 887 |
Średni wolumen | 336 670 |
Kapitalizacja rynkowa | 1.31B |
EPS | $0 ( 2024-05-03 ) |
Last Dividend | $0.100 ( 2012-09-26 ) |
Next Dividend | $0 ( N/A ) |
P/E | -62.49 |
ATR14 | $0.901 (0.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-13 | Davis Stephen L | Sell | 500 | Common Stock |
2023-06-13 | Hasenmaier Joachim A. | Sell | 2 004 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 4 056 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 33 111 | Common Stock |
2022-02-28 | Eyl Steven M. | Buy | 20 000 | Non-Qualified Stock Option (right to buy) |
INSIDER POWER |
---|
-9.09 |
Last 100 transactions |
Buy: 575 941 | Sell: 596 011 |
Wolumen Korelacja
Heska Corp Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SRRA | 0.981 |
SCPL | 0.979 |
KIN | 0.972 |
ADSE | 0.96 |
CDRO | 0.959 |
ICVX | 0.959 |
BWC | 0.958 |
CSII | 0.958 |
TXRH | 0.956 |
MEDP | 0.956 |
10 Najbardziej negatywne korelacje | |
---|---|
CYAN | -0.977 |
QDEL | -0.973 |
PYR | -0.962 |
SSRM | -0.954 |
IMKTA | -0.954 |
AUPH | -0.954 |
PENN | -0.954 |
PTE | -0.953 |
IRDM | -0.95 |
ALNY | -0.948 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Heska Corp Korelacja - Waluta/Towar
Heska Corp Finanse
Annual | 2022 |
Przychody: | $257.31M |
Zysk brutto: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2022 |
Przychody: | $257.31M |
Zysk brutto: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2021 |
Przychody: | $253.74M |
Zysk brutto: | $105.79M (41.69 %) |
EPS: | $-0.110 |
FY | 2020 |
Przychody: | $197.32M |
Zysk brutto: | $81.29M (41.20 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
Heska Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2012-03-28 |
Last Dividend | $0.100 | 2012-09-26 |
Next Dividend | $0 | N/A |
Payout Date | 2012-10-10 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.56 | -- |
Div. Sustainability Score | 3.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.0941 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.300 | 4.08% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.106 | 1.500 | -2.12 | -3.18 | [0 - 0.5] |
returnOnAssetsTTM | -0.0230 | 1.200 | -0.766 | -0.920 | [0 - 0.3] |
returnOnEquityTTM | -0.0324 | 1.500 | -1.472 | -2.21 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.64 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.82 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.96 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.185 | -1.500 | 6.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.49 | 1.000 | -4.25 | -4.25 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.708 | -1.417 | [0 - 20] |
debtEquityRatioTTM | 0.262 | -1.500 | 8.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.429 | 1.000 | 6.18 | 6.18 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0920 | 1.000 | -3.84 | -3.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.113 | 1.000 | -1.737 | -1.737 | [0.2 - 2] |
assetTurnoverTTM | 0.217 | 0.800 | -1.886 | -1.508 | [0.5 - 2] |
Total Score | 3.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -91.49 | 1.000 | -9.34 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0324 | 2.50 | -0.946 | -2.21 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.472 | -1.417 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.830 | 1.500 | -8.87 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0957 | 1.000 | -4.89 | 0 | [0.1 - 0.5] |
Total Score | -2.83 |
Heska Corp
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej